248 related articles for article (PubMed ID: 13397421)
1. Metabolic effects of arylsulfonylurea compounds in normal subjects and in diabetic patients.
CONN JW; FAJANS SS; HENNES AR; WAJCHENBERG BL
Diabetes; 1957; 6(1):41-3; discussion, 43-5. PubMed ID: 13397421
[No Abstract] [Full Text] [Related]
2. Metabolic effects of arylsulfonylurea compounds in normal men and in diabetic subjects.
ACKERMAN IP; CONN JW; FAJANS SS; GITTLER RD; HENNES AR; JOHNSON RD; LOUIS LH; SELTZER HS; WAJCHENBERG BL
Metabolism; 1956 Nov; 5(6 Part 2):820-39. PubMed ID: 13378052
[No Abstract] [Full Text] [Related]
3. Observations in diabetic subjects treated with sulfonylurea compounds.
BROWN F; FRISKEY R; KINSELL LW; SPLITTER TS; TALPERS SJ
Diabetes; 1957; 6(1):64-7; discussion, 85-90. PubMed ID: 13397428
[No Abstract] [Full Text] [Related]
4. Metabolic studies with the arylsulfonylureas.
KUHL WJ
Diabetes; 1957; 6(1):61; discussion, 62. PubMed ID: 13397426
[No Abstract] [Full Text] [Related]
5. Effects of sulfonylurea drugs in hospitalized diabetic patients.
RICKETTS HT; WILDBERGER HL
Diabetes; 1957; 6(1):62-4; discussion, 85-90. PubMed ID: 13397427
[No Abstract] [Full Text] [Related]
6. Effects of sulfonylurea drugs in hospitalized diabetic patients.
RICKETTS HT; WILDBERGER HL
J Am Med Assoc; 1956 Nov; 162(11):1045-9. PubMed ID: 13366706
[No Abstract] [Full Text] [Related]
7. The mechanism of action of the sulfonylureas in diabetes mellitus.
LEVINE R; SOBEL GW
Diabetes; 1957; 6(3):263-9. PubMed ID: 13427633
[No Abstract] [Full Text] [Related]
8. Tolbutamide in treatment of diabetes mellitus.
BUTTERFIELD WJ; FRY IK; HARDWICK C; HOLLING HE
Br Med J; 1957 Aug; 2(5040):325-7. PubMed ID: 13446469
[No Abstract] [Full Text] [Related]
9. Present state of knowledge concerning effects of the sulfonylurea compounds in diabetes mellitus; report of the Committee on Summarization of the Conference.
KRAHL ME; LUKENS FD; RICKETTS HT
Diabetes; 1957; 6(1):91-2. PubMed ID: 13397436
[No Abstract] [Full Text] [Related]
10. Clinical experience and experimental studies with tolbutamide.
CRAIG JW; MILLER M
Diabetes; 1957; 6(1):77-9; discussion, 85-90. PubMed ID: 13397433
[No Abstract] [Full Text] [Related]
11. Current status of aryl sulfonylureas in treatment of diabetes mellitus.
DAVIDSON JW; UNGER RH
J Am Med Assoc; 1956 Sep; 162(5):447-53. PubMed ID: 13357329
[No Abstract] [Full Text] [Related]
12. New orally effective adjuvants in the management of diabetes mellitus.
O'DONOVAN CJ
J Chronic Dis; 1956 Dec; 4(6):635-43. PubMed ID: 13376693
[No Abstract] [Full Text] [Related]
13. Sulfonylureas and diabetes mellitus. I. Clinical evaluation.
COX RW; FERGUS EB; HENLEY ED; WILLIAMS RH
Diabetes; 1956; 5(5):358-65. PubMed ID: 13365475
[No Abstract] [Full Text] [Related]
14. Tolbutamide in diabetes; some clinical and biochemical studies.
CROWLEY MF; WOLFF FW; BLOOM A
Br Med J; 1957 Aug; 2(5040):327-31. PubMed ID: 13446470
[No Abstract] [Full Text] [Related]
15. Effects of tolbutamide and carbutamide on thyroid function.
BROWN J; SOLOMON DH
Metabolism; 1956 Nov; 5(6 Part 2):813-9. PubMed ID: 13378051
[No Abstract] [Full Text] [Related]
16. Clinical experience with tolbutamide.
WALKER G; SLATER JD; WESTLAKE EK; NABARRO JD
Br Med J; 1957 Aug; 2(5040):323-5. PubMed ID: 13446468
[No Abstract] [Full Text] [Related]
17. Oral treatment of diabetes mellitus with the sulfonamide BZ-55.
HERNBERG CA
Acta Endocrinol (Copenh); 1956 Nov; 23(3):281-8. PubMed ID: 13381391
[No Abstract] [Full Text] [Related]
18. The hypoglucemic sulfonylurea drugs; an interim evaluation.
STETTEN D
Ann Intern Med; 1957 May; 46(5):1005-8. PubMed ID: 13411912
[No Abstract] [Full Text] [Related]
19. Clinical experience and experimental studies with tolbutamide.
CRAIG JW; MILLER M
Diabetes; 1957; 6(3):280-2; discussion, 282-9. PubMed ID: 13427636
[No Abstract] [Full Text] [Related]
20. Clinical use of oral sulfonylurea compounds in diabetes mellitus.
COLWELL AR; COLWELL JA
Q Bull Northwest Univ Med Sch; 1957; 31(2):102-13. PubMed ID: 13453644
[No Abstract] [Full Text] [Related]
[Next] [New Search]
